We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$163M
AUM Growth
+$7.91M
Cap. Flow
-$529K
Cap. Flow %
-0.32%
Top 10 Hldgs %
60.11%
Holding
50
New
1
Increased
10
Reduced
36
Closed
–

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$186K
2
ALXN
Alexion Pharmaceuticals
ALXN
+$52.5K
3
BIDU icon
Baidu
BIDU
+$50.2K
4
GILD icon
Gilead Sciences
GILD
+$31.9K
5
BIIB icon
Biogen
BIIB
+$26.2K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$138K
2
VIPS icon
Vipshop
VIPS
+$75.9K
3
WBA
Walgreens Boots Alliance
WBA
+$55.5K
4
ISRG icon
Intuitive Surgical
ISRG
+$51.9K
5
BIVV
Bioverativ Inc. Common Stock
BIVV
+$47.3K

Sector Composition

Rank Sector Weight
1 Healthcare 33.52%
2 Consumer Discretionary 27.17%
3 Technology 22.14%
4 Communication Services 12.71%
5 Industrials 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMI icon
26
Kinder Morgan
KMI
$70.6B
$854K 0.52%
44,579
-433
-1% -$8.61K
JNJ icon
27
Johnson & Johnson
JNJ
$641B
$737K 0.45%
5,569
-170
-3% -$21.7K
BMY icon
28
Bristol-Myers Squibb
BMY
$128B
$697K 0.43%
12,513
-508
-4% -$27.6K
NSC icon
29
Norfolk Southern
NSC
$77.1B
$591K 0.36%
4,855
-105
-2% -$12.3K
ABT icon
30
Abbott
ABT
$182B
$582K 0.36%
11,966
-495
-4% -$22.4K
TTSH
31
DELISTED
Tile Shop Holdings
TTSH
$553K 0.34%
26,774
-1,557
-5% -$31.6K
NEE icon
32
NextEra Energy
NEE
$185B
$518K 0.32%
14,796
-420
-3% -$14.4K
T icon
33
AT&T
T
$167B
$507K 0.31%
17,801
+529
+3% +$15.6K
LLY icon
34
Eli Lilly
LLY
$1.07T
$496K 0.3%
6,028
-333
-5% -$27.2K
PFE icon
35
Pfizer
PFE
$141B
$464K 0.28%
14,568
-1,160
-7% -$36.6K
JPM icon
36
JPMorgan Chase
JPM
$947B
$463K 0.28%
5,067
-165
-3% -$14.2K
PAYX icon
37
Paychex
PAYX
$41.1B
$452K 0.28%
7,943
-420
-5% -$24.7K
MRK icon
38
Merck
MRK
$323B
$426K 0.26%
6,966
-273
-4% -$16.6K
NUE icon
39
Nucor
NUE
$56.4B
$324K 0.2%
5,601
– –
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
$289K 0.18%
3,695
-675
-15% -$55.5K
COST icon
41
Costco
COST
$422B
$282K 0.17%
1,765
-75
-4% -$12.9K
SLB icon
42
SLB Ltd
SLB
$76.5B
$267K 0.16%
4,052
-145
-3% -$10.4K
VZ icon
43
Verizon
VZ
$198B
$266K 0.16%
5,963
-10
-0.2% -$466
IP icon
44
International Paper
IP
$22.5B
$233K 0.14%
4,353
– –
DUK icon
45
Duke Energy
DUK
$100B
$230K 0.14%
2,757
-130
-5% -$10.9K
CVX icon
46
Chevron
CVX
$378B
$228K 0.14%
2,190
-135
-6% -$14.3K
TROW icon
47
T. Rowe Price
TROW
$25.5B
$214K 0.13%
2,878
-195
-6% -$13.9K
BIVV
48
DELISTED
Bioverativ Inc. Common Stock
BIVV
$209K 0.13%
3,481
-830
-19% -$47.3K
ORCL icon
49
Oracle
ORCL
$345B
$205K 0.13%
+4,092
New +$186K
ET icon
50
Energy Transfer Partners
ET
$68.5B
$191K 0.12%
10,611
– –
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Bender Robert & Associates held 50 positions worth $163M, up 5.1% from $155M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 2%. Bender Robert & Associates opened 1 new position and made no exits, leaving the 50-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bender Robert & Associates's largest Q2 2017 buy was Oracle: 4,092 shares worth $205K.
  • Bender Robert & Associates added most to Alexion Pharmaceuticals in Q2 2017, an estimated $52.5K increase.
  • Bender Robert & Associates's biggest Q2 2017 reduction was Apple, cutting an estimated $138K.
  • Bender Robert & Associates's ten largest holdings make up 60% of its $163M portfolio in Q2 2017.
  • Bender Robert & Associates opened 1 new position and closed 0 in Q2 2017.
  • Bender Robert & Associates's portfolio value rose 5.1% quarter-over-quarter to $163M.

Based on Bender Robert & Associates's 13F filing for Q2 2017, filed 3 Aug 2017.